Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.8040 (-1.96%) ($5.6800 - $5.9440) on Mon. Nov. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 28 | Latest Price | $5.8040(-1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -2.4% a day on average for past five trading days. | Weekly Trend | EYES declines -4.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) IGOV(7%) UNG(7%) FIVG(4%) ICLN(4%) | Factors Impacting EYES price | EYES will decline at least -1.73% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) QQQ(-6%) LQD(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
1 - 5 Day Possible Target | $-2.04(-135.15%) | Resistance Level | $6.49 | 5 Day Moving Average | $6.14(-5.47%) | 10 Day Moving Average | $6.38(-9.03%) | 20 Day Moving Average | $6.49(-10.57%) | To recent high | -24.4% | To recent low | 0% | Market Cap | $1.854b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |